Premium
The prognosis of impaired left ventricular systolic function and heart failure in a middle‐aged and elderly population in an urban population segment of Copenhagen
Author(s) -
Raymond Ilan,
Mehlsen Jesper,
Pedersen Frants,
Dimsits Jeannett,
Jacobsen Jørgen,
Hildebrandt Per Rossen
Publication year - 2004
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2003.11.007
Subject(s) - medicine , heart failure , asymptomatic , ejection fraction , cardiology , population , cardiac function curve , environmental health
Aims: To determine the prognosis, total mortality and cardiac morbidity, of patients with left ventricular systolic dysfunction and heart failure (HF) in a general population sample. Methods and results: A total of 764 subjects, 432 females and 332 males, median age (range) 66 years (50–89), participated in this cross sectional survey. The study population was recruited from randomly selected general practitioners and stratified to include a minimum of 150 persons in each age decade stratum. Each participant filled in a heart failure questionnaire and ECG, blood tests and echocardiography were performed. Median (range) follow‐up was 1145 (51–1197) days. Subjects with LVEF≤0.40 had a significantly higher all‐cause mortality (27.8% vs. 5.6%, P< 0.0001), admission rate for HF (25.0% vs. 1.9%, P< 0.0001) and for other cardiac causes (25.0% vs. 6.3%, P< 0.0001) than in subjects with LVEF>0.40. The age and gender adjusted 2‐year relative risk of death was 4.6 (95% C.I.=1.6–13.2). No significant difference in mortality was found between subjects with or without heart failure symptoms. Conclusion: Significantly higher mortality as well as cardiac morbidity was found in subjects with symptomatic and asymptomatic LV systolic dysfunction compared to those with normal systolic function. These conditions were among the strongest predictors of all‐cause mortality and cardiac morbidity.